Author Correction: Phosphoinositide 3-Kinase (PI3K) Subunit p110δ Is Essential for Trophoblast Cell Differentiation and Placental Development in Mouse

被引：0
|
作者：
Xiwen Hu
Jiangchao Li
Qianqian Zhang
Lingyun Zheng
Guang Wang
Xiaohan Zhang
Jingli Zhang
Quliang Gu
Yuxiang Ye
Sun-Wei Guo
Xuesong Yang
Lijing Wang
机构：
[1] Guangdong Pharmaceutical University,Vascular Biology Research Institute
[2] Guangdong Pharmaceutical University,School of Basic Courses
[3] Division of Histology & Embryology,Key Laboratory for Regenerative Medicine of the Ministry of Education
[4] Medical College,undefined
[5] Jinan University,undefined
[6] Shanghai OB/GYN Hospital,undefined
[7] Fudan University,undefined
[8] Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases,undefined
[9] Fudan University,undefined
来源：
Scientific Reports | / 10卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
A correction has been published and is appended to both the HTML and PDF versions of this paper. The error has not been fixed in the paper.
引用
收藏
相关论文
共 50 条
  • [31] Combined Pharmacological Inhibition of Bruton's Tyrosine Kinase (BTK) and Phosphoinositide 3-Kinase (PI3K) p110δ Rescues Monocytosis, Thrombocytopenia, and Splenomegaly in a Genetic Mouse Model for JMML
    Patel, Roshni
    Ramdas, Baskar
    Deng, Lisa
    Jideonwo-Auman, Victoria
    Chan, Rebecca J.
    Kapur, Reuben
    BLOOD, 2018, 132
  • [32] Essential role for the p110δ isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia
    Sujobert, P
    Bardet, V
    Cornillet-Lefebvre, P
    Hayflick, JS
    Prie, N
    Verdier, F
    Vanhaesebroeck, B
    Muller, O
    Pesce, F
    Ifrah, N
    Hunault-Berger, M
    Berthou, C
    Villemagne, B
    Jourdan, E
    Audhuy, B
    Solary, E
    Witz, B
    Harousseau, JL
    Himberlin, C
    Lamy, T
    Lioure, B
    Cahn, JY
    Dreyfus, F
    Mayeux, P
    Lacombe, C
    Bouscary, D
    BLOOD, 2005, 106 (03) : 1063 - 1066
  • [33] Advances in the Development of Class I Phosphoinositide 3-Kinase (PI3K) Inhibitors
    Sabbah, Dima A.
    Hu, Jian
    Zhong, Haizhen A.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2016, 16 (13) : 1413 - 1426
  • [34] Enhanced Akt phosphorylation and myogenic differentiation in PI3K p110β-deficient myoblasts is mediated by PI3K p110α and mTORC2
    Matheny, Ronald W., Jr.
    Lynch, Christine M.
    Leandry, Luis A.
    GROWTH FACTORS, 2012, 30 (06) : 367 - 384
  • [35] Novel approaches to inhibitor design for the p110β phosphoinositide 3-kinase
    Dbouk, Hashem A.
    Backer, Jonathan M.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2013, 34 (03) : 149 - 153
  • [36] The p110δ isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells
    Okkenhaug, Klaus
    Patton, Daniel T.
    Bilancio, Antonio
    Garcon, Fabien
    Rowan, Wendy C.
    Vanhaesebroeck, Bart
    JOURNAL OF IMMUNOLOGY, 2006, 177 (08): : 5122 - 5128
  • [37] Structure, function and inhibition of the phosphoinositide 3-kinase p110α enzyme
    Flanagan, Jack U.
    Shepherd, Peter R.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2014, 42 : 120 - 124
  • [38] Hot-spot mutations in p110α of phosphatidylinositol 3-kinase (PI3K) Differential interactions with the regulatory subunit p85 and with RAS
    Zhao, Li
    Vogt, Peter K.
    CELL CYCLE, 2010, 9 (03) : 596 - 600
  • [39] Small Molecule Inhibitors of Phosphoinositide 3-Kinase (PI3K) δ and γ
    Ameriks, Michael K.
    Venable, Jennifer D.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2009, 9 (08) : 738 - 753
  • [40] Regulation of p110δ PI 3-Kinase Gene Expression
    Kok, Klaartje
    Nock, Gemma E.
    Verrall, Elizabeth A. G.
    Mitchell, Michael P.
    Hommes, Daan W.
    Peppelenbosch, Maikel P.
    Vanhaesebroeck, Bart
    PLOS ONE, 2009, 4 (04):
12345